Client News

New York & Shandong Province, February 4, 2009 - Gulf Resources, Inc. (OTCBB: GFRE) (“Gulf Resources” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in the People’s Republic of China, today announced that one of its wholly-owned subsidiaries Shouguang City Haoyuan Chemical Company Limited (“SCHC”) has completed the acquisition of manufacturing assets involved in bromine and crude salt production owned by three individual residents of the People’s Republic of China, Fenqiu Yuan, Han Wang and Yufen Zhang (the “Sellers”).

TAIYUAN, SHANXI, China, February 3, 2009 – Puda Coal, Inc. (OTC BB: PUDC) (“Puda Coal” or the “Company”), a supplier of China's high grade metallurgical coking coal used to make coke for the purposes of steel manufacturing, today announced that the Company signed a letter of intent with a local county government located in Shanxi Province (“the County”) to consolidate the County’s six coal mines (“the coal mines”) and construct a coal gangue power plant.

KAIFENG, CHINA, February 3, 2009 – China Valves Technology, Inc. (OTCBB: CVVT) ("China Valves” or the “Company"), a leading metal valve manufacturer with operations in the People's Republic of China (the “PRC”), today announced that the Company’s Chairman and CEO, Mr. Siping Fang, was named one of “Thirty Famous Non-State Owned Enterprise Entrepreneurs During 30 Years of Reform and Opening up in Henan Province.”

BEIJING, China – February 3, 2009 – China TransInfo Technology Corp., (NASDAQ: CTFO) (“China TransInfo” or “the Company”), a leading provider of public transportation information systems technology and comprehensive solutions in the People’s Republic of China (“PRC”), today announced that it has completed its corporate restructuring by entering into a series of contractual arrangement with various parties to more clearly separate its business segments and centralize business management (“VIE Restructuring”).

Wuxi, China, February 2, 2009 — WSP Holdings Limited (NYSE: WH) (“WSP Holdings” or the “Company”), a leading Chinese manufacturer of API (American Petroleum Institute) and non-API seamless casing, tubing and drill pipes used in oil and natural gas exploration, drilling and extraction (“Oil Country Tubular Goods” or “OCTG”), and other pipes and connectors, today announced that its wholly-owned subsidiary Wuxi Seamless Oil Pipes Company Limited (“WSP China”) won several contracts to supply a total of 142,777 metric tons of OCTG to China National Petroleum Corporation (“CNPC”),

Laiyang, China, January 29, 2008 – Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) (“Genesis” or the “Company”), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that Laiyang Jiangbo Pharmaceutical Co., Ltd. (“Laiyang”), a wholly-owned subsidiary of the Company, entered into an Assets Transfer Contract (the “Contract”) with Shandong Chinese Traditional Medicine College (the “Medicine College”) and Hongrui Pharmaceuticals, Ltd.

Wuxi, China, January 21, 2009 — WSP Holdings Limited (NYSE: WH) (“WSP Holdings” or the “Company”), a leading Chinese manufacturer of API (American Petroleum Institute) and non-API seamless casing, tubing and drill pipes used in oil and natural gas exploration, drilling and extraction (“Oil Country Tubular Goods” or “OCTG”), and other pipes and connectors, today provided an update to its guidance for fiscal year 2008.

HARBIN, China, Jan. 15 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today provided an update on its business.

Weifang, Shandong province, P.R.C. January 14, 2009 – Yuhe International Inc. (OTC BB: YUII) (“Yuhe” or “the Company”), a leading supplier of day-old chickens raised for meat production, or broilers, in the People’s Republic of China (“PRC”), today announced that the Company was awarded a certificate of recognition by the Weifang Municipal Industrial and Commercial Association for the Company’s contribution to relief efforts for the earthquake in Sichuan province in May 2008.

Laiyang, China, January 13, 2009 – Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) (“Genesis” or the “Company”), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today announced that it engaged KPMG Huazhen (“KPMG”), a member firm of the KPMG network of independent member firms affiliated with KPMG International, to assist the Company in complying with the financial reporting and control requirements of Sarbanes-Oxley Act Section 404 ("SOX 404").